The AGA Institute is seeking public comment on the new guideline, “Evaluation of functional diarrhea and diarrhea predominant irritable bowel syndrome in adults (IBS-D).” This guideline aims to help clinicians choose the appropriate laboratory tests to exclude other diagnoses when functional diarrhea or IBS-D is suspected. These guidelines apply to patients with “watery” diarrhea for at least six weeks and excludes patients with bloody diarrhea; diarrhea with signs of fat malabsorption; features of alarm symptoms, such as weight loss, anemia and hypoalbuminemia; a family history of inflammatory bowel disease, colon cancer or celiac disease; and those with a travel history to regions with recognized specific diarrhea-related pathogens.
Review and submit feedback by March 27
The AGA Institute is seeking public comment on the clinical practice guideline, clinical decision support tool and technical review for the evaluation of functional diarrhea or IBS-D. Please review the following documents:
Submit your comments by completing this survey. The public comment period will end at noon EDT on Wednesday, March 27.
Learn more about AGA’s clinical practice guidelines.